JVMCX
Price
$28.15
Change
-$0.89 (-3.06%)
Updated
Dec 18 closing price
NMVLX
Price
$12.21
Change
-$1.09 (-8.20%)
Updated
Dec 18 closing price
Ad is loading...

JVMCX vs NMVLX

Header iconJVMCX vs NMVLX Comparison
Open Charts JVMCX vs NMVLXBanner chart's image
JHancock Disciplined Value Mid Cap C
Price$28.15
Change-$0.89 (-3.06%)
VolumeN/A
CapitalizationN/A
Nuance Mid Cap Value Institutional
Price$12.21
Change-$1.09 (-8.20%)
VolumeN/A
CapitalizationN/A
JVMCX vs NMVLX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JVMCX vs. NMVLX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVMCX is a Hold and NMVLX is a Hold.

FUNDAMENTALS
Fundamentals
JVMCX has more cash in the bank: 23.4B vs. NMVLX (1.47B). NMVLX pays higher dividends than JVMCX: NMVLX (1.73) vs JVMCX (0.01). JVMCX was incepted earlier than NMVLX: JVMCX (13 years) vs NMVLX (11 years). NMVLX is a more actively managed with annual turnover of: 62.00 vs. JVMCX (41.00). JVMCX has a lower initial minimum investment than NMVLX: JVMCX (1000) vs NMVLX (10000). JVMCX (9.81) and NMVLX (9.70) have marching annual gain over last year. JVMCX return over 5 years is better than : 36.55 vs. NMVLX (-0.34).
JVMCXNMVLXJVMCX / NMVLX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years11 years-
Gain YTD12.0377.786155%
Front LoadN/AN/A-
Min. Initial Investment10001000010%
Min. Initial Investment IRAN/AN/A-
Net Assets23.4B1.47B1,596%
Annual Yield % from dividends0.011.731%
Returns for 1 year9.819.70101%
Returns for 3 years14.98-8.74-172%
Returns for 5 years36.55-0.34-10,747%
Returns for 10 years48.1136.07133%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TPCS3.550.07
+2.01%
TechPrecision Corp
HLN9.910.19
+1.95%
Haleon plc
GKOS146.352.22
+1.54%
Glaukos Corp
SAFT83.38-0.27
-0.32%
Safety Insurance Group
SLN6.51-0.23
-3.41%
Silence Therapeutics Plc